Desmopressin nasal spray solution 0.01% is contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin nasal spray solution 0.01%
They may be used when a provider determines that a compounded option is appropriate for an individual patient
By the 2026 clinical consensus, leading medical organizations have solidified the classification of obesity as a complex, relapsing metabolic disease that requires long-term pharmaceutical and lifestyle intervention
As mentioned earlier, semaglutide can lead to up to 15% weight loss, which is higher than many other weight-loss medications
In July 2024, during a presidential campaign town hall, Kennedy referred to Americans who take psychiatric medications for ADHD, depression and anxiety as addicts. He shared his plan to send Americans living with addiction including presumably people with mental health diagnoses to wellness farms in rural areas
An earlier Phase II trial11 and two essentially identical Phase III trials (a study of at least moderate size that compares a new treatment with the current standard of care in patients), Gout 1 and Gout 2 have been presented.13 Data on shrinkage of tophi with this agent was also presented in 6/09.13 Cardiac events have occurred during the studies of Krystexxa, and the FDA reviewed them closely and concluded that they did not appear due to the medication